US House Appropriators Request CBD Enforcement As They Ante Up $5M For FDA's Rule Development
Executive Summary
Appropriation Committee members target $5m for FDA's CBD policy work and suggest the agency enforce against noncompliant firms in their report accompanying legislation proposing the agency’s fiscal 2021 budget.
You may also be interested in...
Funding For US FDA Work On Cannabinoids Regulatory Pathway Drives Progress Only So Far
FDA is conducting lab testing on CBD products with funding in its FY2021 appropriations, says senior agency advisor Sharon Mayl. Some work planned work in the area has been delayed by the agency's response to COVID-19.
Senate Appropriators Ask USDA To Remove Business ‘Roadblocks’ In Hemp Production Rule
Senate committee “is concerned” USDA's interim final rule “creates roadblocks for farmers” by imposing short timeframes for testing harvested hemp for levels of THC in crops and requiring testing only by DEA-registered labs.
Temporary Funding For US Agencies Delays $5M For FDA’s Cannabidiols Regulatory Pathway Work
Senate on 29 September was expected to a pass a CR the House passed a week earlier to fund FDA and other federal departments and agencies through 11 December.